North America Autologous Cell Therapy Market Size, Share, Growth, and Industry Analysis, By Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells), By Application (Oncology, Orthopedics, Neurology), Regional Insights and Forecast to 2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: North America Autologous Cell Therapy Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on North America Autologous Cell Therapy Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. North America Autologous Cell Therapy Market , By Type
   1. Introduction
      1. Market Size and Forecast, By Type
   2. Hematopoietic Stem Cells
      1. Market Size and Forecast, By Region
   3. Mesenchymal Stem Cells
      1. Market Size and Forecast, By Region
   4. Induced Pluripotent Stem Cells
      1. Market Size and Forecast, By Region
10. North America Autologous Cell Therapy Market , By Application
    1. Introduction
       1. Market Size and Forecast, By Application
    2. Oncology
       1. Market Size and Forecast, By Region
    3. Orthopedics
       1. Market Size and Forecast, By Region
    4. Neurology
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. North America
       1. Market Size and Forecast
          1. By Type
             1. Hematopoietic Stem Cells
             2. Mesenchymal Stem Cells
             3. Induced Pluripotent Stem Cells
          2. By Application
             1. Oncology
             2. Orthopedics
             3. Neurology
       2. U.S.
          1. By Type
             1. Hematopoietic Stem Cells
             2. Mesenchymal Stem Cells
             3. Induced Pluripotent Stem Cells
          2. By Application
             1. Oncology
             2. Orthopedics
             3. Neurology
       3. Canada
12. Competitive Landscape, 2025
    1. Introduction
    2. North America Autologous Cell Therapy Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. Fate Therapeutics
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Mesoblast Limited
    3. Pluristem Therapeutics Inc.
    4. Athersys, Inc.
    5. Century Therapeutics
    6. Gamida Cell Ltd.
    7. Vericel Corporation
    8. Celyad Oncology
    9. Sangamo Therapeutics
    10. Caladrius Biosciences
    11. Adaptimmune Therapeutics
    12. Autolus Therapeutics
    13. Novartis AG
    14. Kite Pharma